By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556




Company News
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Preclinical Analgesic Effects 5/9/2017 8:57:42 AM
Addex Therapeutics (ADXN.SW) ADX71441 Preclinical Results for Treatment of Alcohol Use Disorder Published in Journal of Psychopharmacology 5/4/2017 11:38:45 AM
Addex Therapeutics (ADXN.SW) Provides Corporate Update And Reports 2016 Financial Results 4/5/2017 12:51:46 PM
Addex Therapeutics (ADXN.SW) Raises CHF3.0 Million Through Private Placement Of Treasury Shares And Extends Cash Runway Through 2018 2/28/2017 9:08:10 AM
Addex Therapeutics (ADXN.SW)'s ADX71149 Anti-Epileptic Effect Highlighted In Scientific Journal, Epilepsia 2/27/2017 8:25:56 AM
Addex Therapeutics (ADXN.SW)' Clinical Programs And Discovery Platform Highlighted In Review Of Allosteric Modulators For The Treatment Of Neurodegenerative Diseases 2/6/2017 8:42:58 AM
Addex Therapeutics (ADXN.SW) Awarded $835,000 Grant From The Michael J. Fox Foundation To Advance TrkB PAMs For The Treatment Of Parkinson's Disease 1/31/2017 10:17:14 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Statistically Significant Efficacy In A Highly Translational Preclinical Model Of Chronic Osteoarthritis Pain 1/9/2017 9:48:15 AM
Addex Therapeutics (ADXN.SW) ADX71441 Pharmacological Profile Published In Neuropharmacology 12/13/2016 8:36:27 AM
Addex Therapeutics (ADXN.SW) Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., As Chief Medical Officer 11/28/2016 7:30:48 AM